Tag: Biomarker Discovery,Combination Therapy,Press Releases,advanced melanoma,biomarker research,cancer immunotherapy,circulating proteome
-
Society for Advanced Bronchoscopy Commits to Enhance Education and Practice Excellence as U.S. Demand for Bronchoscopy Procedures Increases
At second meeting, members share the latest clinical and administrative best practices supporting continued, high-quality patient care
-
Society for Advanced Bronchoscopy Meets May 20 to Address “Hot Topics in Advanced Bronchoscopy”
New organization focuses on enhancing skills and knowledge necessary to meet growing demand, provide highest quality care for patients undergoing bronchoscopy
-
New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions
BOULDER, Colo., April 30, 2018 (GLOBE NEWSWIRE) — New data presented at the American College of Medical Quality (ACMQ) 2018 conference (Medical Quality 2018) demonstrate that a blood-based proteomic test reliably assesses individual patient prognosis to inform treatment decisions and reduce costs associated with overtreatment in lung cancer. The Biodesix VeriStrat® test provided objective…
-
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate Pharmaceuticals (Cambridge, MA), a clinical-stage biopharmaceutical company focused on developing novel approaches for cancer immunotherapy.